| Home | E-Submission | Sitemap | Contact Us |  
J Neurocrit Care > Browse Articles > J Neurocrit Care



Successful treatment with rituximab in a patient with lupus cerebritis and posterior reversible encephalopathy syndrome: a case report
Saemi Choi, Young Seo Kim
J Neurocrit Care. 2021;14(2):103-108.   Published online December 24, 2021
doi: https://doi.org/10.18700/jnc.210028
                  CrossRef - TDM            
Favorable clinical course after early-intensive immunotherapy for new-onset refractory status epilepticus
Hyun-Sung Kim, Jiyoung Kim, Bo-Jin Hwang, Kyoung-Nam Woo, Min-Gyu Park, Kyung-Pil Park, Sung-Ho Ahn
J Neurocrit Care. 2020;13(1):65-68.   Published online June 15, 2020
doi: https://doi.org/10.18700/jnc.190115
                  CrossRef - TDM            
Consciousness Recovery by Rituximab after Seizure Control in Cryptogenic New-Onset Refractory Status Epilepticus
Tae-Won Yang, Jeong Won Jo, Do-Hyung Kim, Young-Soo Kim, Oh-Young Kwon
J Neurocrit Care. 2018;11(2):137-142.   Published online December 21, 2018
doi: https://doi.org/10.18700/jnc.180066
                  CrossRef - TDM            
1 |
E-Submission
Endnote Style File
Endnote Style File
Email Alert
Author's Index
Supranuclear oculomotor palsy in cerebral venous sinus thrombosis: a case report. J Neurocrit Care. 2021;14:113-116
The author of the accepted manuscript will receive two mugs, printed with an abstract design. We look forward to your continued interest in and support for this journal.
Korean Neurocritical Care Society

First decision

18 Days

Publication after acceptance

53 Days

Submission to publication

103 Days

Acceptance rate

53 %

*Last 12 months

Editorial Office
88, Olympic-ro 43-gil, Songpa-gu, Seoul, Korea
TEL : +82-2-3010-3440    FAX : +82-2-474-4691    E-mail : office@e-jnc.org

Copyright© Korean Neurocritical Care Society.                Developed in M2PI